Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Endometrioid × temsirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 23 Glioblastoma 10 Endometrial Neoplasms 10 Neoplasm Metastasis 8 Lymphoma, Mantle-Cell 8 Prostatic Neoplasms 7 Kidney Neoplasms 7 Breast Neoplasms 7 Brain Neoplasms 7 Sarcoma 6 Neoplasms 6 Melanoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Multiple Myeloma 5 Gliosarcoma 5 Uterine Cervical Neoplasms 4 Oligodendroglioma 4 Lymphoma, Follicular 4 Lymphoma 4 Glioma 4 Fallopian Tube Neoplasms 4 Central Nervous System Neoplasms 4 Astrocytoma 4 Waldenstrom Macroglobulinemia 3 Unspecified Adult Solid Tumor, Protocol Specific 3 Rhabdomyosarcoma 3 Osteosarcoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell, Marginal Zone 3

Interventions

temsirolimus 1 cabozantinib 1 Therapeutics 1 Taxes 1 Radiation, Ionizing 1 Paclitaxel 1 Dasatinib 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02093598 2020-11-27

POEM

MedSIR

Phase 2 Completed

Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡